Skip to main content
Top
Published in: Internal and Emergency Medicine 1/2021

01-01-2021 | Acute Coronary Syndrome | EM - ORIGINAL

The predictive value of the HEART and GRACE scores for major adverse cardiac events in patients with acute chest pain

Authors: Zhenhua Huang, Keke Wang, Daya Yang, Qianlin Gu, Qiuxia Wei, Zhen Yang, Hong Zhan

Published in: Internal and Emergency Medicine | Issue 1/2021

Login to get access

Abstract

The history, electrocardiogram, age, risk factors, troponin (HEART) and global registry of acute coronary events (GRACE) scoring systems are commonly used to risk stratify patients with chest pain. This study investigated the application of these scores in predicting the short-term risk of a major adverse cardiac event (MACE) in patients with chest. A total of 509 patients were analyzed. All patients were followed up for 30 days after visiting our emergency department. At 30 days post-admission, the primary outcome (MACE) was recorded in 92 patients (18.1%), 88 (95.6%) of whom had experienced an acute myocardial infarction. Thirty-seven (40.2%) of the patients with a MACE underwent percutaneous coronary intervention and six patients (6.5%) died. The HEART and GRACE scores were both significantly higher in patients who developed a MACE than in those without (P < 0.05). The HEART and GRACE scores had c-statistic values of 0.811 (95% CI 0.774–0.844) and 0.648 (95% CI 0.603–0.688), respectively. The Hosmer–Lemeshow statistic revealed that the HEART and GRACE scores had values of 8.68 (P = 0.39) and 10.45 (P = 0.11), respectively. The percentages of patients with HEART scores of 0–3, 4–6, and 7–10 were 3.0%, 26.2%, and 46.3%, respectively, in those with a MACE within 30 days. The findings show that while both scoring systems are useful, the HEART score is superior to the GRACE score for predicting the occurrence of MACE within 30 days in patients with chest pain.
Literature
6.
go back to reference Khan E, Brieger D, Amerena J et al (2018) Differences in management and outcomes for men and women with ST-elevation myocardial infarction. Med J Aust 209(3):118–123CrossRef Khan E, Brieger D, Amerena J et al (2018) Differences in management and outcomes for men and women with ST-elevation myocardial infarction. Med J Aust 209(3):118–123CrossRef
Metadata
Title
The predictive value of the HEART and GRACE scores for major adverse cardiac events in patients with acute chest pain
Authors
Zhenhua Huang
Keke Wang
Daya Yang
Qianlin Gu
Qiuxia Wei
Zhen Yang
Hong Zhan
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 1/2021
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02378-0

Other articles of this Issue 1/2021

Internal and Emergency Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine